Recurrent vulvovaginal candidiasis associated with long-term tamoxifen treatment in postmenopausal women

Obstetrics and Gynecology

Volumn 88, Issue 4 II SUPPL., 1996, Pages 704-706

  Sobel, Jack D ^a,b   Chaim, Walter ^a   Leaman, Deborah ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Harper Professional Building ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; TAMOXIFEN;

ADULT; AGED; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CASE REPORT; FEMALE; HUMAN; INFECTION RISK; POSTMENOPAUSE; PRIORITY JOURNAL; VAGINA CANDIDIASIS;

EID: 0029761323     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/0029-7844(96)00123-8     Document Type: Article

References (13)

1. Odds FC. Genital candidosis. In: Odds FC, ed. Candida and Candidosis; a review and bibliography. 2nd ed. London: Bailliere Tindall, 1988:124-35.
2. Hurley R, De Louvois J. Candida vaginitis. Postgrad Med J 1979; 55:645-7.
3. Davidson F, Oates JK. The pill does not cause "thrush." Br J Obstet Gynaecol 1985;92:1265-8.
4. Kinsman OS, Collard AE. Hormonal factors in vaginal candidiasis in rats. Infect Immun 1986;53:498-504.
5. McCourtie J, Douglas LG. Relationship between cell surface composition of Candida albicans and adherence to acrylic after-growth on different carbon sources. Infect Immun 1981;32:1234-41.
6. Kinsman OS. Effect of mammalian steroid hormones and luteinizing hormone on germination of Candida albicans and implications for vaginal candidosis. Mycoses 1988;31:617-26.
7. Loose DS, Feldman D. Characterization of a unique corticosterone-binding protein in Candida albicans. J Biol Chem 1982;257:4925-30.
8. Gorodeski GI, Beery R, Lunenfeld B, Geier A. Tamoxifen increases plasma estrogen-binding equivalents and has an estradiol agonistic effect on histologically normal premenopausal and postmenopausal endometrium. Fertil Steril 1992;57:320-7.
9. Bhatavdekar JM, Shah NG, Patel DD, Karelia NH, Trivedi SN, Vora HH, et al. Endocrine function in premenopausal and post-menopausal advanced cancer patients treated with CMF or tamoxifen. Neoplasma 1992;39:123-7.
10. Eells TP, Alpern HD, Grzywacz C, MacMillan RW, Olson JE. The effect of tamoxifen on cervical squamous maturation in Papanicolaou stained cervical smears of post-menopausal women. Cytopathology 1990;1:263-8.
11. Turner MLC. Vulvar manifestations of systemic diseases. Dermat Clin 1992;10:445-58.
12. Love RR, Cameron L, Connell BI, Leventhal H. Symptoms associated with tamoxifen treatment in postmenopausal women. Arch Intern Med 1991;151:1842-7.
13. Fisher B, Costantino J, Redmond C, Poisson R, Bowman D, Couture J, et al. A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen receptor-positive tumors. N Engl J Med 1989;320:479-84.